The Current Ratio as of December 2025 (TTM) for NKGen Biotech, Inc. Common Stock (NKGN) is 0

According to NKGen Biotech, Inc. Common Stock’s latest financial reports and current stock price. The company's current Current Ratio is 0. This represents a change of -100.00% compared to the average of 0.02 of the last 4 quarters.

NKGen Biotech, Inc. Common Stock (NKGN) Historical Current Ratio (quarterly & annually)

How has NKGN Current Ratio performed in the past?

The mean historical Current Ratio of NKGen Biotech, Inc. Common Stock over the last ten years is 0.02. The current 0 Current Ratio has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), NKGN's Current Ratio was at its highest in in the June 2021 quarter at 11.65. The Current Ratio was at its lowest in in the March 2021 quarter at 0.

NKGen Biotech, Inc. Common Stock (NKGN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of NKGen Biotech, Inc. Common Stock Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NKGen Biotech, Inc. Common Stock (NKGN) Average Current Ratio

How has NKGN Current Ratio performed in the past?

The current Current Ratio of NKGen Biotech, Inc. Common Stock (NKGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

NKGen Biotech, Inc. Common Stock (NKGN) Current Ratio vs. Peers

How is NKGN’s Current Ratio compared to its peers?

NKGen Biotech, Inc. Common Stock’s Current Ratio is less than Windtree Therapeutics, Inc. (0.33), less than PMGC Holdings Inc. (1.79), less than BriaCell Therapeutics Corp. Warrant (3.41), less than Protagenic Therapeutics, Inc. (0.29), less than XORTX Therapeutics Inc. (1.78), less than Moolec Science S.A. (1.48), less than Virax Biolabs Group Limited (7.27), less than Dermata Therapeutics, Inc. (0), less than Kadimastem Ltd (0), less than Avenue Therapeutics, Inc. (2.61),

Build a custom stock screener for NKGen Biotech, Inc. Common Stock (NKGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NKGen Biotech, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NKGen Biotech, Inc. Common Stock (NKGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NKGen Biotech, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.